IDSA’s new open-access journal, Open Forum Infectious Diseases (OFID), is now accepting manuscripts. As a benefit of membership, all IDSA and HIVMA members receive discounts on publication fees at OFID.
The goal of OFID is to offer the rapid publication of clinical, translational, and basic research for all aspects of Infectious Diseases, with a focus on studies that have the potential to improve patient care. This is a very broad spectrum of content, and could include clinical trials, observational and cohort studies, translational laboratory work, cost-effectiveness/modeling studies, and novel diagnostic and therapeutic algorithms, among others. In addition to research and review articles, the journal also plans to publish educational pieces that move the field forward.
In recognition of the professional excellence that Fellows of IDSA (FIDSAs) have achieved and their significant service to the field of infectious diseases, OFID has established a privileged peer review track, designed to speed publication and help ensure the success of the new journal. Fellows of IDSA (FIDSAs) may submit one manuscript per year via this track, which will facilitate a faster publication process. To qualify, you must be an author of the paper. You select your own reviewers (who may not be collaborators on the research project), revise the manuscript based on the reviewers’ comments, and then submit the revised manuscript with the reviews to the editorial office. Manuscripts may be sent out for additional peer review, and based on the feedback from all of the reviewers and the judgment of the editorial team, a decision will be made. While there is not a guarantee of publication, this accelerated track will result in quicker decisions.
To submit your manuscript, either via the FIDSA track or the regular track, read the instructions to authors and submit online.
< Previous Article | Next Article >